Selank vs oxytocin for anxiety: what the trials found
Reviewed 27 sourcesPublished by PepVault
Selank vs oxytocin for anxiety: every human anxiety trial of each side by side, with its size, what it was compared with and what it found, as of November 2026.

- Last reviewed
- Sources
- 27
- Questions
- 8
- Compounds
- 2
The short answer
Selank has more positive anxiety trials; oxytocin has better-designed ones. Selank, a Russian nasal drop, eased anxiety about as much as the benzodiazepine medazepam in a 62-patient trial, but no Selank trial used a placebo. Oxytocin, the body's own hormone, was tested against dummy sprays, and in anxiety disorders it did not reduce core symptoms. Neither is approved for anxiety in the US.
Evidence: Human evidence: Selank, three small Russian trials against or with benzodiazepines, none with a placebo; oxytocin, small placebo-controlled trials in social anxiety and phobia that did not improve core symptoms, and one 328-patient trial in acute stress after surgery. No study has compared the two.

What are Selank and oxytocin?
Selank is a lab-made chain of seven amino acids (Thr-Lys-Pro-Arg-Pro-Gly-Pro), an analogue of tuftsin, a small peptide of the immune system15. Russia sells it as 0.15% nasal drops, 1.5 mg of Selank in each mL, without a prescription, and files it with the anxiolytics, the drugs that relieve anxiety (ATC code N05BX)1. Its entry in Vidal, Russia's drug reference, lists anxiety, panic attacks, neurasthenia (lasting fatigue and irritability), sleep problems and stress disorders1.
Oxytocin is the body's own hormone, a chain of nine amino acids made in the hypothalamus and released from the pituitary gland. Medicine knows it as the hormone that drives labor contractions19. Brain research knows it for something else: it changes how the amygdala, the brain's threat detector, reacts to fear and to other people10. That second job is why it is tested for anxiety.

Is Selank or oxytocin approved for anxiety?
Only Selank, and only in Russia. Here is where each stands as of November 20, 2026:
| Status | Selank | Oxytocin |
|---|---|---|
| Approved for anxiety | Yes, in Russia: nasal drops, sold without a prescription; re-registered July 15, 2025, replacing an earlier registration1 | No: no oxytocin label we found lists anxiety |
| What the FDA has approved | Nothing: Drugs@FDA lists no application for Selank20 | Injections only (Pitocin and generics), for labor with a medical reason and bleeding after birth19 |
| A nasal product in the US | None approved | The Syntocinon nasal spray is listed as discontinued18 |
So in the US neither one is an anxiety medicine: oxytocin for anxiety is off-label, and Selank is not an approved drug for any use. FDA lists Selank among the compounding substances whose nominations were withdrawn from its safety-risk category, where it notes a possible immune reaction (page current April 22, 2026)21. Our legal status pages for Selank and oxytocin carry the full FDA, DEA and WADA records.
How does each act on anxiety?
Selank works on the brain's own calming chemistry, by two routes the studies measured. In human blood serum in a lab dish, it slowed the enzymes that break down enkephalins, the body's own opioid-like mood peptides5. In the 62-patient anxiety trial, patients started with enkephalin that broke down faster than normal, and on Selank that improved, most clearly in generalized anxiety2. In rats, one dose changed the activity of 29 of 77 brain-signalling genes within an hour, and the changes tracked those that GABA itself caused; GABA is the brain's main calming signal and the system benzodiazepines act on6.
Oxytocin works on the threat circuit. In 18 people with social anxiety disorder, the amygdala over-reacted to fearful faces on a brain scan; after one 24 IU spray of oxytocin that over-reaction was gone, while it did nothing in 18 people without anxiety10. In 37 healthy men facing a stressful public-speaking test, oxytocin plus a best friend's support gave the lowest levels of the stress hormone cortisol, with more calm and less anxiety during the test11. More is not always better: in mice, 15 days of a high oxytocin dose infused into the brain made the animals more anxious, while a low dose protected them from stress12.
Species note: the gene result is from rats and the infusion result from mice; the enzyme result is serum in a dish. The brain-scan and stress-test results are from people, measured over an hour or two.
What did the anxiety trials measure?
These are the human anxiety trials of each that report a size. No study has given both, so the table puts them side by side rather than head to head.
| Study | Who | Size | Compared with | What it found |
|---|---|---|---|---|
| Selank: Zozulia 20082 | Generalized anxiety and neurasthenia | 62 (30 Selank, 32 medazepam) | Medazepam, a benzodiazepine | Similar anxiety relief; Selank also eased fatigue |
| Selank: Medvedev 20143 | Phobic, anxiety and somatoform disorders | 60 | Phenazepam, a benzodiazepine | Clear anxiety relief; the effect lasted a week after the last dose |
| Selank: Medvedev 20154 | Anxiety-phobic and somatoform disorders | 70 (40 with Selank, 30 without) | Phenazepam alone | Phenazepam worked sooner and with fewer of its side effects when Selank was added |
| Oxytocin: Guastella 20097 | Social anxiety disorder, with exposure therapy | 25 | Placebo spray | Rated their own speeches better; symptoms fell the same in both groups |
| Oxytocin: Acheson 20158 | Fear of spiders, one exposure session | 23 (10 oxytocin, 13 placebo) | Placebo spray | Self-rated fear tended to improve less with oxytocin at 1 week and 1 month |
| Oxytocin: Voncken 20219 | Social anxiety disorder, two live social tasks | 40 patients, 39 controls | Placebo spray | Observers rated social behavior better in one task; patients felt no difference |
| Oxytocin: Sabino 202023 | Music performance anxiety | 43 male musicians, each given both | Placebo spray (crossover) | No change in mood or anxiety; the most anxious read happy faces better |
| Oxytocin: UCSD pilot, 2009-201116 | Generalized anxiety, social anxiety, PTSD | 17 enrolled | Placebo spray | Stopped when funding ended; the data were never analysed |
| Oxytocin: Huang 202615 | Adults before fracture surgery | 328 | Placebo spray | Probable acute stress disorder within 3 days: 15.9% vs 30.5% |
Two things stand out. Every Selank trial was positive and none had a dummy drug, so none can separate the drug from expectation. Oxytocin's anxiety-disorder trials had dummy sprays, and in them the symptoms people rated did not move. Its clearest result is the 2026 surgery trial: one 40 IU spray 10 minutes before anesthesia halved the share who screened positive for probable acute stress disorder, a short-term reaction to trauma rather than an anxiety disorder15.
How strong is the evidence for each?
Selank: thin, and from one circle. None of the three trial abstracts describes how patients were randomized or says anyone was blinded, and all are published in Russian with an English abstract234. All three list the same chemist, N. F. Myasoedov of the Institute of Molecular Genetics in Moscow, among their authors, as does the rat gene study2346; we found no Selank anxiety trial from an independent group. ClinicalTrials.gov holds no Selank trial25. A 2021 US review called Selank a poorly studied Russian drug22.
Oxytocin: more trials, smaller effects than the early headlines. A 2019 systematic review of 15 placebo-controlled trials in anxiety and depression, 7 of them in social anxiety, found no significant effect on core symptoms; most tested a single dose13. A 2026 meta-analysis of 42 trials across mental disorders, 1,922 people, found a small effect that was not significant overall14. A review of single-dose threat studies found that only one of 26 was large enough to detect a moderate effect26.
The two weaknesses run in opposite directions. Selank has the positive results but not the design that would make them convincing; oxytocin has the design, and the design mostly came back empty for anxiety symptoms. The open question for oxytocin is the schedule: in 147 people with high or low trait anxiety, a spray every other day calmed the over-reacting threat circuit of the anxious group on brain scans, and a daily spray for five days did not show that effect24.
How are Selank and oxytocin taken?
Both by nose, and both clear the blood within minutes. Selank comes as drops: its Vidal entry states 92.8% bioavailability through the nose, Selank in the blood within 30 seconds, and blood levels falling over 5 to 5.5 minutes, without saying whether that was measured in people or animals1. Oxytocin lasts about 1 to 6 minutes in the blood19. In the trials it is a spray, most often 24 IU791011, given 40 to 50 minutes before the test in two of them911. A review of 38 trials from 1990 to 2010 found doses of 18 to 40 IU, mostly single doses and up to 182 doses in all17. These are the reference's and the trials' figures, not a dosing plan.
Add Selank or oxytocin from the PepVault library and it is set up as a nasal dose: each one logs with a tap, with no injection site to record. Log it in PepVault
Is Selank or oxytocin better for anxiety?
For everyday anxiety, Selank has the stronger case on paper: it is the only one of the two built, registered and tested as an anxiety drug, and in trials against two benzodiazepines it relieved anxiety, matching medazepam123. That case rests on small, unblinded Russian trials. Oxytocin is the better-studied molecule, and its trials point to something narrower: a short-lived shift in how people handle a social or stressful moment, rather than lower anxiety from week to week91115.
So the trials match each one to a different question. Lasting, general anxiety is the question Selank's trials asked. A single moment, such as a social encounter or surgery, is the one oxytocin's trials answered best. Neither has been tested against today's first-line anxiety treatments, talk therapy and SSRI antidepressants.
Commonly reported: of 22 people whose open write-ups on Selank we counted, 19 described an effect they wanted, most often feeling calmer, and none described one they did not. For oxytocin we found only 3 write-ups: one described a benefit, and between them they named headaches, an upset stomach and the effect fading.
What side effects do the labels and trials list?
Few. Selank's Vidal entry lists allergic reactions in people sensitive to it and an unpleasant taste when drops run into the throat, and rules out pregnancy, breastfeeding and anyone under 181. Added to phenazepam, Selank lowered phenazepam's own side effects, such as sleepiness and memory lapses4. For oxytocin, the review of 38 trials found side effects no different from the dummy spray, and people could not tell which one they had taken17. Oxytocin also contracts the uterus, which is why Brazil's oxytocin spray label rules it out in pregnancy27.
PepVault's daily check-in rates your mood from one to five stars, with a note for the day, beside your doses, so you can see your own pattern over weeks. Log it in PepVault
When to get help If anxiety is getting in the way of work, sleep or relationships, or comes with panic attacks, a doctor or therapist is the right first stop: talk therapy and approved anxiety medicines have far larger trials behind them than either peptide.
Sources
- Vidal Russia. Selank 0.15% nasal drops: registration ЛП-№(010951)-(РГ-RU) of July 15, 2025 (previous ЛСР-003338/09), holder Peptogen; drug reference entry (composition, pharmacokinetics, indications, side effects, contraindications; the entry marks it as sold without a prescription). Read November 20, 2026. vidal.ru
- Zozulia AA et al. Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia. Zh Nevrol Psikhiatr Im S S Korsakova. 2008. PubMed 18454096
- Medvedev VE et al. A comparison of the anxiolytic effect and tolerability of selank and phenazepam in the treatment of anxiety disorders. Zh Nevrol Psikhiatr Im S S Korsakova. 2014. PubMed 25176261
- Medvedev VE et al. Optimization of the treatment of anxiety disorders with selank. Zh Nevrol Psikhiatr Im S S Korsakova. 2015. PubMed 26356395
- Kost NV et al. Semax and selank inhibit the enkephalin-degrading enzymes from human serum. Bioorg Khim. 2001. PubMed 11443939
- Volkova A et al. Selank administration affects the expression of some genes involved in GABAergic neurotransmission. Front Pharmacol. 2016. PubMed 26924987
- Guastella AJ et al. A randomized controlled trial of intranasal oxytocin as an adjunct to exposure therapy for social anxiety disorder. Psychoneuroendocrinology. 2009. PubMed 19246160
- Acheson DT et al. Intranasal oxytocin administration prior to exposure therapy for arachnophobia impedes treatment response. Depress Anxiety. 2015. PubMed 25826649
- Voncken MJ et al. The effect of intranasally administered oxytocin on observed social behavior in social anxiety disorder. Eur Neuropsychopharmacol. 2021. PubMed 34358819
- Labuschagne I et al. Oxytocin attenuates amygdala reactivity to fear in generalized social anxiety disorder. Neuropsychopharmacology. 2010. PubMed 20720535
- Heinrichs M et al. Social support and oxytocin interact to suppress cortisol and subjective responses to psychosocial stress. Biol Psychiatry. 2003. PubMed 14675803
- Peters S et al. Dose-dependent effects of chronic central infusion of oxytocin on anxiety, oxytocin receptor binding and stress-related parameters in mice. Psychoneuroendocrinology. 2014. PubMed 24636519
- De Cagna F et al. The role of intranasal oxytocin in anxiety and depressive disorders: a systematic review of randomized controlled trials. Clin Psychopharmacol Neurosci. 2019. PubMed 30690935
- Bonnieux J et al. Does intranasal oxytocin reduce symptoms of mental disorders? A meta-analysis of clinical trials. Neurosci Biobehav Rev. 2026. PubMed 42134427
- Huang Q et al. Preoperative intranasal oxytocin and probable acute stress disorder after traumatic fracture surgery: a randomized clinical trial. JAMA Intern Med. 2026. PubMed 42931765
- ClinicalTrials.gov NCT00989937. Double-blind, randomized, placebo-controlled, cross-over pilot study of intranasal oxytocin in patients with anxiety disorder (University of California, San Diego; terminated, 17 enrolled; data not analysed). Read November 20, 2026. clinicaltrials.gov
- MacDonald E et al. A review of safety, side-effects and subjective reactions to intranasal oxytocin in human research. Psychoneuroendocrinology. 2011. PubMed 21429671
- U.S. Food and Drug Administration. Drugs@FDA: Syntocinon (oxytocin) nasal solution, NDA 012285, marketing status discontinued. Read November 20, 2026. accessdata.fda.gov
- Pitocin (oxytocin injection, USP) prescribing information. DailyMed, National Library of Medicine. Read November 20, 2026. dailymed.nlm.nih.gov
- FDA. Drugs@FDA, searched through the openFDA drugsfda endpoint for selank on November 20, 2026: no matches. api.fda.gov
- FDA. Certain bulk drug substances for use in compounding that may present significant safety risks (content current as of April 22, 2026). fda.gov
- Doyno CR, White CM. Sedative-hypnotic agents that impact gamma-aminobutyric acid receptors: focus on flunitrazepam, gamma-hydroxybutyric acid, phenibut, and selank. J Clin Pharmacol. 2021. PubMed 34396551
- Sabino ADV et al. Acute effects of oxytocin in music performance anxiety: a crossover, randomized, placebo-controlled trial. Psychopharmacology (Berl). 2020. PubMed 32123973
- Kou J et al. Anxiolytic effects of chronic intranasal oxytocin on neural responses to threat are dose-frequency dependent. Psychother Psychosom. 2022. PubMed 35086102
- ClinicalTrials.gov API v2, intervention search for selank on November 20, 2026: two records, neither a Selank study. clinicaltrials.gov
- Leppanen J et al. Meta-analytic review of the effects of a single dose of intranasal oxytocin on threat processing in humans. J Affect Disord. 2018. PubMed 28837950
- Syntocinon (ocitocina) 40 UI/mL solução spray nasal: bula para o profissional de saúde. Mylan Laboratórios (Viatris), Brazil; approved by ANVISA March 11, 2021. viatris.com
Newsletter · Weekly
The weekly peptide briefing.
New guides, the week’s peptide news, one tool. Free, one email a week, unsubscribe anytime.